Dr. West Discusses ALK-NSCLC Crizotinib Survival Benefit

onclivetv has 407 videos Subscribe Here

Description: H. Jack West, MD, medical director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle, Washington discusses how crizotinib in ALK-non-small cell lung cancer (NSCLC) demonstrated a survival benefit.
Shared By : onclivetv
Posted on : 06/30/11
Added : 6 years ago

More From onclivetv

Nothing found.